Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Lithuanian biotech growing fast

31.03.2008
The Lithuanian biotech sector's sales have grown by about 22 % each year for the last 5 years according to the Lithuanian Biotechnology Association. Two modern biotechnology companies: Fermentas Ltd. and Sicor Biotech Ltd. operate in Lithuania for more than 10 years. The sales of both companies in 2007 exceeded 28 mln. Euros.

Fermentas Ltd. is a R&D and manufacturing company, which develop and produce products for genetic engineering, molecular biology, genomic research and other biotechnological investigations (over 400 items). More than 99 % of the products are exported. Expansion of efforts to the field of molecular diagnostics is taking place at the present time. Big scale production of kits for molecular diagnostics is planned.

The enterprise of biotechnological pharmacy Sicor Biotech Ltd. in Lithuania is producing recombinant proteins for medical use (interferon alpha-2b, human growth hormone, granulocyte colonies stimulating factor, erythropoietin). It is the only factory of such a profile in Eastern and Central Europe. Sicor Biotech Ltd. is a member of TEVA group (TEVA Pharmaceutical Industries Ltd., Israel). It has strong and very well equipped research centre, developing technologies for production of recombinant proteins.

The success of Lithuanian Biotech is underscored by the fact that the Institute of Biotechnology in Vilnius has attracted back to Lithuania seventeen (17) scientists who have spent over 3 years abroad. They have now returned to carry out their research in Lithuania bringing with them experience, knowledge and funds.

... more about:
»Bioregion »Biotech »Biotechnology »Lithuanian

The Lithuanian government has increased funding of biotech research in the last five years and established new programs such as the Industrial Biotechnology Program. Very appropriate, this year's ScanBalt Forum takes place in Vilnius 24-26 September, organized by the Institute of Biotechnology and the Lithuanian Association of Biotechnology and in parallel with the annual ScanBalt Biomaterial Days. Read more at http://www.scanbalt.org/forum2008

The responsible organizer of ScanBalt Forum 2008, dr. Daumantas Matulis, the head of Laboratory of Biothermodynamics and Drug Design, Institute of Biotechnology, says: "The growing importance of life sciences and biotechnology in Lithuania is being recognized with ScanBalt Forum 2008 to take place in Vilnius. This is a chance to promote Lithuania as an attractive place to work, live and invest. We intend to further strengthen our position as a strong player within life sciences and biotechnology in the Baltic Sea Region - also called ScanBalt BioRegion".

For further information contact Daumantas Matulis at: +370 650 06560 or matulis@ibt.lt

About Institute of Biotechnology:
IBT is State Research Institute and the leading biotechnology center in Lithuania active in multidisciplinary studies of restriction - modification enzymes, and the research and development of recombinant biomedical proteins. IBT has 7 laboratories specializing in Protein-DNA Interactions, Biological DNA Modification, Prokaryote Gene Engineering, Eukaryote Gene Engineering, Immunology, Biothermodynamics and Drug Design and Bioinformatics.
IBT aims to strengthen the cooperation in the field of Biochemistry, Biotechnology and Biomedicine, enhance networking of academic and industrial sectors and the development of international collaboration and knowledge exchange by maintaining the stimulating competitiveness both in research and commercial applications. IBT boost the initiation of the dialogue with policy makers, best scientific, business leaders on national and international scale.

Read more at http://www.ibt.lt

About ScanBalt BioRegion and ScanBalt:
ScanBalt BioRegion is composed of Life Science and biotechnology actors in the Nordic, Baltic countries, Poland, Northern part of Germany and North western Russia. The ScanBalt BioRegion have 11 countries and 85 million people, more than 60 universities and 2173 life science/biotech companies including 671 research based biotech SME´s. ScanBalt facilitates and co-ordinates regional and national efforts in ScanBalt BioRegion. It enhances visibility and attracts human, industrial and financial resources to the region and to the members. ScanBalt encompasses regional and national life science triple helix networks between companies, universities, hospitals, tech transfer organisations and public authorities.

Peter Frank | idw
Further information:
http://www.scanbalt.org
http://www.scanbalt.org/forum2008

Further reports about: Bioregion Biotech Biotechnology Lithuanian

More articles from Life Sciences:

nachricht Microscope measures muscle weakness
16.11.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

nachricht Good preparation is half the digestion
16.11.2018 | Max-Planck-Institut für Stoffwechselforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>